Department of Cardiovascular and Respiratory Sciences, Respiratory Diseases Unit, Sapienza University of Rome, Fondazione E. Lorillard Spencer Cenci, Rome, Italy.
Eur Rev Med Pharmacol Sci. 2010 Oct;14(10):809-21.
Ultrafine particles or nanoparticles (UFPs or PM0.1) are the fraction of ambient particulates with an aerodynamic diameter smaller than 0.1 microm. Currently UFPs are emerging as the most abundant particulate pollutants in urban and industrial areas, as their exposures have increased dramatically because of anthropogenic sources such as internal combustion engines, power plants, incinerators and many other sources of thermo-degradation. Ultrafine particles have been less studied than PM2.5 and PM10 particulates, mass concentrations of particles smaller than 2.5 and 10 microm, respectively. OBJECTIVE, EVIDENCE AND INFORMATION SOURCES: We examined the current scientific literature about the health effects of ultrafine particles exposure.
UFPs are able to inhibit phagocytosis, and to stimulate inflammatory responses, damaging epithelial cells and potentially gaining access to the interstitium. They could be responsible for consistent reductions in forced expiratory volume in 1 second (FEV1) and forced vital capacity (FVC) in patients with asthma. Chronic exposure to UFPs can produce deleterious effects on the lung, also causing oxidative stress and enhancing pro-inflammatory effects in airways of COPD patients. Cardiovascular detrimental consequences due to UFPs exposure have observed in epidemiological studies, and could likely be explained by translocation of UFPs from the respiratory epithelium towards circulation and subsequent toxicity to vascular endothelium; alteration of blood coagulation; triggering of autonomic nervous system reflexes eventually altering the cardiac frequency and function. Once deposited deeply into the lung, UFPs--in contrast to larger-sized particles--appear to access to the blood circulation by different transfer routes and mechanisms, resulting in distribution throughout the body, including the brain, with potential neurotoxic consequences.
UFPs represent an area of toxicology of emerging concern. A new concept of environmental medicine would help in understanding not only the environmental mechanisms of disease, but also in developing specific preventive or therapeutic strategies for minimizing the dangerous influence of pollution on health.
超细颗粒或纳米颗粒(UFPs 或 PM0.1)是指空气动力学直径小于 0.1 微米的环境颗粒物的一部分。目前,UFPs 作为城市和工业区中最丰富的颗粒污染物而出现,因为人类活动来源(如内燃机、发电厂、焚烧炉和许多其他热降解源)导致它们的暴露量急剧增加。与 PM2.5 和 PM10 颗粒物相比,超细颗粒的研究较少,PM2.5 和 PM10 颗粒物分别指小于 2.5 和 10 微米的颗粒物的质量浓度。
目的、证据和信息来源:我们研究了关于超细颗粒暴露对健康影响的当前科学文献。
UFPs 能够抑制吞噬作用,并刺激炎症反应,损伤上皮细胞,并可能进入间质。它们可能是导致哮喘患者的 1 秒用力呼气量(FEV1)和用力肺活量(FVC)持续下降的原因。慢性暴露于 UFPs 会对肺部产生有害影响,还会导致 COPD 患者气道中的氧化应激和促炎作用增强。流行病学研究观察到由于 UFPs 暴露导致心血管不良后果,这可能是由于 UFPs 从呼吸上皮转移到循环中,并随后对血管内皮产生毒性;血液凝固改变;触发自主神经系统反射,最终改变心脏频率和功能。一旦 UFPs 深深地沉积在肺部,与较大粒径的颗粒相比,它们似乎通过不同的转移途径和机制进入血液循环,导致全身分布,包括大脑,可能产生神经毒性后果。
UFPs 代表一个新兴关注的毒理学领域。环境医学的新概念将有助于不仅理解疾病的环境机制,而且还开发出针对最小化污染对健康的危险影响的特定预防或治疗策略。